VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions (DG19)Product type:GuidanceProgramme:Diagnostics guidancePublished: 11 November 2015
Artificial Intelligence technologies for assessing skin lesions selected for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointmentsStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: TBC